[DreaMed in Calcalist] DreaMed secures $3M and strategic deals amid CEO’s reserve IDF duty
Israeli startup DreaMed Diabetes, which develops the endo.digital platform that provides AI-based recommendations for the treatment of people with diabetes, announced on Monday that it has raised $3 million and signed several deals with health systems and companies. Read more...
Read More